PDCD1 and neoplasm: The prominent TIM-3 upregulation in CD8+ tumor-infiltrating lymphocytes (TILs) and tumor-infiltrating dendritic cells (TIDCs) and the phenomenon of HPD were observed in ID8VEGF-bearing mice after anti-PD-1 treatment.